...
search icon

Price related data not available

Innate Pharma Analyst Forecast

Price related data not available

Innate Pharma Stock Returns

Time FrameIPHASectorS&P500
1-Week Return-10.63%-1.66%-0.96%
1-Month Return-17.82%-4.76%-2.3%
3-Month Return-23.94%-3.81%-2.15%
6-Month Return-31.12%9.66%0.81%
1-Year Return-28.32%4.4%20.8%
3-Year Return-51.69%19.83%72.98%
5-Year Return-69.57%30.13%68.06%
10-Year Return-76.36%119.85%229.83%

Innate Pharma Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue69.77M12.11M57.67M51.90M12.62M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":17.36,"profit":true},{"date":"2022-12-31","value":82.66,"profit":true},{"date":"2023-12-31","value":74.39,"profit":true},{"date":"2024-12-31","value":18.09,"profit":true}]
Cost of Revenue49.71M47.00M51.66M56.02M51.98M[{"date":"2020-12-31","value":88.73,"profit":true},{"date":"2021-12-31","value":83.9,"profit":true},{"date":"2022-12-31","value":92.22,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":92.78,"profit":true}]
Gross Profit20.07M(22.30M)6.01M5.62M12.62M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-111.14,"profit":false},{"date":"2022-12-31","value":29.96,"profit":true},{"date":"2023-12-31","value":28,"profit":true},{"date":"2024-12-31","value":62.9,"profit":true}]
Gross Margin28.76%(184.12%)10.42%10.83%100.00%[{"date":"2020-12-31","value":28.76,"profit":true},{"date":"2021-12-31","value":-184.12,"profit":false},{"date":"2022-12-31","value":10.42,"profit":true},{"date":"2023-12-31","value":10.83,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses18.99M25.52M63.44M18.29M64.20M[{"date":"2020-12-31","value":29.58,"profit":true},{"date":"2021-12-31","value":39.76,"profit":true},{"date":"2022-12-31","value":98.82,"profit":true},{"date":"2023-12-31","value":28.49,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income1.08M(47.83M)(57.42M)(12.67M)(51.58M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-4432.34,"profit":false},{"date":"2022-12-31","value":-5322.06,"profit":false},{"date":"2023-12-31","value":-1174.14,"profit":false},{"date":"2024-12-31","value":-4779.89,"profit":false}]
Total Non-Operating Income/Expense(3.82M)4.69M(1.09M)7.64M3.98M[{"date":"2020-12-31","value":-49.97,"profit":false},{"date":"2021-12-31","value":61.47,"profit":true},{"date":"2022-12-31","value":-14.31,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":52.06,"profit":true}]
Pre-Tax Income(829.00K)(45.48M)(57.97M)(7.57M)(49.47M)[{"date":"2020-12-31","value":-82900000,"profit":false},{"date":"2021-12-31","value":-4547800000,"profit":false},{"date":"2022-12-31","value":-5797200000,"profit":false},{"date":"2023-12-31","value":-757000000,"profit":false},{"date":"2024-12-31","value":-4947100000,"profit":false}]
Income Taxes6.76M13.66M41.13M(9.73M)-[{"date":"2020-12-31","value":16.44,"profit":true},{"date":"2021-12-31","value":33.21,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-23.65,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(7.59M)(59.14M)(99.10M)2.16M-[{"date":"2020-12-31","value":-351.64,"profit":false},{"date":"2021-12-31","value":-2739.05,"profit":false},{"date":"2022-12-31","value":-4590.23,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(63.98M)(45.48M)(57.97M)(7.57M)(49.47M)[{"date":"2020-12-31","value":-6398400000,"profit":false},{"date":"2021-12-31","value":-4547800000,"profit":false},{"date":"2022-12-31","value":-5797200000,"profit":false},{"date":"2023-12-31","value":-757000000,"profit":false},{"date":"2024-12-31","value":-4947100000,"profit":false}]
Income From Discontinued Operations(7.33M)(7.33M)(131.00K)--[{"date":"2020-12-31","value":-733100000,"profit":false},{"date":"2021-12-31","value":-733100000,"profit":false},{"date":"2022-12-31","value":-13100000,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(63.98M)(52.81M)(58.10M)(7.57M)(49.47M)[{"date":"2020-12-31","value":-6398400000,"profit":false},{"date":"2021-12-31","value":-5280900000,"profit":false},{"date":"2022-12-31","value":-5810300000,"profit":false},{"date":"2023-12-31","value":-757000000,"profit":false},{"date":"2024-12-31","value":-4947100000,"profit":false}]
EPS (Diluted)(0.43)(0.84)(0.16)0.02(0.30)[{"date":"2020-12-31","value":-2134,"profit":false},{"date":"2021-12-31","value":-4200,"profit":false},{"date":"2022-12-31","value":-800,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-1500,"profit":false}]

Innate Pharma Ratios

Innate Pharma Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

IPHA
Cash Ratio 2.04
Current Ratio 2.21

Innate Pharma Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

IPHA
ROA (LTM) -25.92%
ROE (LTM) -271.37%

Innate Pharma Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

IPHA
Debt Ratio Lower is generally better. Negative is bad. 0.94
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.06

Innate Pharma Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

IPHA
Trailing PE NM
Forward PE NM
P/S (TTM) 11.13
P/B 24.31
Price/FCF NM
EV/R 15.59
EV/Ebitda NM

FAQs

What is Innate Pharma share price today?

Innate Pharma (IPHA) share price today is $1.5

Can Indians buy Innate Pharma shares?

Yes, Indians can buy shares of Innate Pharma (IPHA) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in IPHA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Innate Pharma be purchased?

Yes, you can purchase fractional shares of Innate Pharma (IPHA) via the Vested app. You can start investing in Innate Pharma (IPHA) with a minimum investment of $1.

How to invest in Innate Pharma shares from India?

You can invest in shares of Innate Pharma (IPHA) via Vested in three simple steps:

  • Click on Sign Up or Invest in IPHA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Innate Pharma shares
What is Innate Pharma 52-week high and low stock price?

The 52-week high price of Innate Pharma (IPHA) is $2.63. The 52-week low price of Innate Pharma (IPHA) is $1.4.

What is Innate Pharma price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Innate Pharma (IPHA) is

What is Innate Pharma price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Innate Pharma (IPHA) is 24.31

What is Innate Pharma dividend yield?

The dividend yield of Innate Pharma (IPHA) is 0.00%

What is the Market Cap of Innate Pharma?

The market capitalization of Innate Pharma (IPHA) is $140.59M

What is Innate Pharma's stock symbol?

The stock symbol (or ticker) of Innate Pharma is IPHA

How Can Investors Use Innate Pharma Share Price Data for Long-Term Investment Decisions?

Consider the share price of Innate Pharma as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Innate Pharma has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Innate Pharma shares for Indian investors?

When investing in Innate Pharma shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Innate Pharma stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Innate Pharma share price with other stocks in the same sector?

Rather than merely checking the share price of Innate Pharma and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Innate Pharma stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top